Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial

Ian E. Krop, Ingrid A. Mayer, Vinod Ganju, Maura Dickler, Stephen Johnston, Serafin Morales, Denise A. Yardley, Bohuslav Melichar, Andres Forero-Torres, Soo Chin Lee, Richard de Boer, Katarina Petrakova, Susanne Vallentin, Edith A. Perez, Martine Piccart, Matthew Ellis, Eric Winer, Steven Gendreau, Mika Derynck, Mark LacknerGallia Levy, Jiaheng Qiu, Jing He, Peter Schmid

Research output: Contribution to journal › Article › peer-review

165 Scopus citations

Fingerprint

Dive into the research topics of 'Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences